Factors impacting branch vessel patency—ophthalmic arterya
| Patent Branch Vessel | Occluded Branch Vessel | Univariate P Value | Multivariate P Value | OR (95% CI) | |
|---|---|---|---|---|---|
| Mean patient age (yr) | 53.8 | 60.1 | .119 | ||
| Male | 15 (12.7%) | 0 (0%) | .283 | ||
| Mean max aneurysm sac | 5.9 ± 3.8 | 5.8 ± 3.3 | .977 | ||
| Mean aneurysm neck size | 3.6 ± 1.6 | 3.6 ± 0.5 | .998 | ||
| Acutely ruptured target lesion | 4/118 (3.7%) | 0/7 (0%) | .597 | ||
| Prior coiling | 29/118 (24.6%) | 1/7 (14.3%) | .438 | ||
| Mean procedural time (min) | 200 ± 63 | 212 ± 60 | .628 | ||
| Mean fluoroscopy time (min) | 63 ± 37 | 53 ± 28 | .429 | ||
| >1 PED deployed | 10/118 (8.5%) | 0/7 (0%) | .391 | ||
| % PED classic | 70/75 (93.3%) | 5/75 (6.7%) | .859 | ||
| Balloon angioplasty | 9/118 (7.6%) | 0/7 (0%) | .418 | ||
| Mean PED diameter (mm) | 4.1 ± 0.5 | 3.4 ± 0.6 | <0.001 | <.001 | 0.10 (0.04–0.21) |
| Mean Δmax size of parent vessel and PED | 0.23 ± 0.18 | 0.24 ± 0.21 | .887 | ||
| Mean Δmin size of parent vessel and PED | 0.79 ± 0.41 | 0.79 ± 0.48 | .979 | ||
| Branch vessel incorporation into aneurysm sac | 31/118 (26.3%) | 2/7 (29%) | .937 | ||
| Mean periprocedural P2Y12 | 136 ± 68 | 150 ± 63 | .597 | ||
| Intraprocedural administration of abciximab | 5/118 (4.2%) | 2/7 (29%) | .013 | .194 | 4.09 (0.49–34.19) |
| Presence of endothelial hyperplasia | 26/115 (22.6%) | 3/7 (43%) | .337 | ||
| Mean length of DSA follow-up (mo) | 17.9 ± 9.9 | 21.4 ± 13.8 | .682 |
↵a Percentages reflect analysis per branch vessel.